<Home> <Newsletter> <Third Issue> <Vaccine Safety: Index> Issue No. 003/09 20 November2009   Main Topic: H1N1 FLU (SWINEFLU) VACCINE SAFETY I N D E X 2009 H1N1 Vaccination Recommendations CDC Advisors Make Recommendations for Use of Vaccine Against Novel H1N1 Pandemic influenza vaccines: current status - Pandemic (H1N1) 2009 briefing note 11 FDA Approves Vaccines for 2009 H1N1 Influenza Virus - Approval Provides Important Tool to Fight Pandemic Influenza A (H1N1) 2009 Monovalent Vaccines Questions and Answers European Medicines Agency recoomends authorisation of additional vaccine for influenza pandemic (H1N1) 2009 Influenza A (H1N1) 2009 Monovalent Vaccine Safety Monitoring One Dose of H1N1 Vaccine Immunogenic in High Percentage of Youth Ages 10 to 17 - Younger Children Likely Will Need Two Doses - By David Mitchell AAN Collaborates With CDC On H1N1 Vaccine Safety Monitoring 2009 H1N1 Influenza Vaccine and Pregnant Women Update on Influenza A (H1N1) 2009 Monovalent Vaccines CDC Offers Reassurances on H1N1 Vaccine Safety - By Robert Lowes General Questions and Answers on Guillain-Barré syndrome (GBS) Influenza A (H1N1) 2009 Monovalent Influenza A (H1N1) 2009 Monovalent Vaccines Description and Ingredient 2009 H1N1 Influenza - Just the Facts Vaccine Essentials - John G. Bartlett, MD Thimoresal in Vaccines General Questions and Answers on Thimerosal H1N1 vaccine safety becomes an issue in Canada - Posted Oct 23, 2009 by Stephanie Dearing IOMS Newsletter - 20 November 2009   Issue No. 003/09     Back to Main Page (Contents) 1st Issue: No.001/09, 01 April 2009 2nd Issue: No.002/09, 12 August 2009